Suzana Blazanovic

Ms. Suzana Blazanovic

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EKElizabeta Knezović
Elizabeta Knezović
MHMarija Hefer
Marija Hefer
Suzana BlazanovicSuzana Blazanovic
Suzana Blazanovic
APAna Petrovic
Ana Petrovic
VTVice Tomičić
Vice Tomičić
MSMartina Smolic
Martina Smolic
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), represent a growing global health problem linked to obesity, insulin resistance, and dyslipidemia. MASLD often leads to fibrosis, cirrhosis, and hepatocellular carcinoma. Currently, therapeutic options are limited, emphasizing the need for novel, targeted pharmacological interventions. Resmetirom, a selective thyroid hormone receptor beta (THR-β) agonist, offers a promising approach by specifically enhancing hepatic metabolism while minimizing systemic effects. Clinical trials have demonstrated its capacity to reduce hepatic triglyceride accumulation and improve lipid profiles. Early- and advanced-phase studies, including the MAESTRO program, highlight significant reductions in hepatic fat content and favorable impacts on noninvasive biomarkers of fibrosis with minimal side effects. This review highlights evidence from pivotal studies, explores resmetirom’s mechanism of action, and compares its efficacy and safety with other emerging therapeutic agents. While resmetirom marks a breakthrough in non-cirrhotic MASH management, further long-term studies are essential to fully evaluate its clinical benefits and potential regulatory approval for broader use in MASLD and MASH.

Verified
Journal Article
Open access
PDF file
EKElizabeta Knezović
Elizabeta Knezović
MHMarija Hefer
Marija Hefer
Suzana BlazanovicSuzana Blazanovic
Suzana Blazanovic
APAna Petrovic
Ana Petrovic
VTVice Tomičić
Vice Tomičić
MSMartina Smolic
Martina Smolic
There was an error in the original publication